Metsera shareholders vote for $10 billion acquisition by PfizerNov 13 (Reuters) - Metsera MTSR.O shareholders on Thursday approved Pfizer's PFE.N takeover offer worth up to $10 billion, allowing the U.S. pharmaceutical giant re-entry into the lucrative obesity treatment market after a fierce bidding war with Wegovy-maker Novo Nordisk NOVOb.CO.
(Reporting by Kamal Choudhury and Mariam Sunny in Bengaluru; Editing by Maju Samuel)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments